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Background: Adaptive servo-ventilation (ASV) therapy has been shown to improve cardiac function in patients with heart failure (HF). Accelerated 
sympathetic nerve activity (SNA) is associated with a poor prognosis of HF patients. We investigated whether ASV therapy could improve cardiac SNA 
in HF patients by using cardiac 11C-Hydroxyephedrine positron emission tomography (11C-HED PET).
Methods: Nine HF patients (age: 57.3±17.3 years old, male: 6, female: 3, left ventricular ejection fraction (LVEF): 36.1±16.7%) regardless of sleep 
disordered breathing were enrolled. We performed to measure parameters of echocardiography, polysomnography, and cardiac SNA before and 6 
months after initiating ASV. Cardiac SNA was analyzed by plasma and urinary noradrenalin, and 11C-HED retention index based on PET imaging.
results: LVEF tended to improve 6 months after ASV therapy, however, did not reach statistical significant difference (LVEF: from 36.1±16.7 to 
39.2±16.3%, p=0.09). Apnea hypopnea index decreased from 22.3±14.4 to 2.3±3.3/hour (p=0.009). Plasma and urinary noradrenalin did not 
change 6 months after ASV therapy. Global 11C-HED retention index improved from 0.068±0.032 to 0.089±0.045 (p=0.04).
conclusions: ASV therapy improved cardiac SNA in HF patients. Thus, SNA quantification by 11C-HED PET may provide further diagnostic 
information over standard modality.
